secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2026-09-14T20:02:18+00:00
Accession:  0001367644-26-000091
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions CEO presentation at H.C. Wainwright provides no new financial details
--------------------------------------------------------------------------------

- Joseph C. Papa, President and CEO, to present at H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026.
- Investor presentation furnished as Exhibit 99.1, titled 'Combating Public Health Threats for Communities Around the World'.
- No specific financial data, guidance, or operational updates appear in the furnished presentation.
- Filing is a Regulation FD disclosure with no other material corporate developments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/0001367644-26-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764426000091/ebs-20260914.htm
  HTML page:      https://secwatch.observer/filing/0001367644-26-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer